181 related articles for article (PubMed ID: 19342453)
41. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
42. Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
Cescato R; Schulz S; Waser B; Eltschinger V; Rivier JE; Wester HJ; Culler M; Ginj M; Liu Q; Schonbrunn A; Reubi JC
J Nucl Med; 2006 Mar; 47(3):502-11. PubMed ID: 16513620
[TBL] [Abstract][Full Text] [Related]
43. Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells.
Ludvigsen E; Stridsberg M; Taylor JE; Culler MD; Oberg K; Janson ET
Med Oncol; 2004; 21(3):285-95. PubMed ID: 15456957
[TBL] [Abstract][Full Text] [Related]
44. [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors.
Siehler S; Seuwen K; Hoyer D
Eur J Pharmacol; 1998 May; 348(2-3):311-20. PubMed ID: 9652348
[TBL] [Abstract][Full Text] [Related]
45. Somatostatin receptor subtype 1 modulates basal inhibition of growth hormone release in somatotrophs.
Kreienkamp HJ; Akgün E; Baumeister H; Meyerhof W; Richter D
FEBS Lett; 1999 Dec; 462(3):464-6. PubMed ID: 10622746
[TBL] [Abstract][Full Text] [Related]
46. Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes.
Malagón MM; Luque RM; Ruiz-Guerrero E; Rodríguez-Pacheco F; García-Navarro S; Casanueva FF; Gracia-Navarro F; Castaño JP
Endocrinology; 2003 Dec; 144(12):5372-80. PubMed ID: 12960033
[TBL] [Abstract][Full Text] [Related]
47. Functional activity of the multiligand analog SOM230 at human recombinant somatostatin receptor subtypes supports its usefulness in neuroendocrine tumors.
Schmid HA; Schoeffter P
Neuroendocrinology; 2004; 80 Suppl 1():47-50. PubMed ID: 15477717
[TBL] [Abstract][Full Text] [Related]
48. Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1/2 activity.
Treppiedi D; Giardino E; Catalano R; Mangili F; Vercesi P; Sala E; Locatelli M; Arosio M; Spada A; Mantovani G; Peverelli E
Mol Cell Endocrinol; 2019 Mar; 483():31-38. PubMed ID: 30611770
[TBL] [Abstract][Full Text] [Related]
49. Somatostatin and dopamine-somatostatin multiple ligands directed towards somatostatin and dopamine receptors in pituitary adenomas.
Saveanu A; Gunz G; Guillen S; Dufour H; Culler MD; Jaquet P
Neuroendocrinology; 2006; 83(3-4):258-63. PubMed ID: 17047391
[TBL] [Abstract][Full Text] [Related]
50. Exploration of the DTrp-NMeLys motif in the search for potent somatostatin antagonists.
Rajeswaran WG; Murphy WA; Taylor JE; Coy DH
Bioorg Med Chem; 2002 Jun; 10(6):2023-9. PubMed ID: 11937362
[TBL] [Abstract][Full Text] [Related]
51. Urotensin II and urotensin II-related peptide activate somatostatin receptor subtypes 2 and 5.
Malagon MM; Molina M; Gahete MD; Duran-Prado M; Martinez-Fuentes AJ; Alcain FJ; Tonon MC; Leprince J; Vaudry H; Castaño JP; Vazquez-Martinez R
Peptides; 2008 May; 29(5):711-20. PubMed ID: 18289730
[TBL] [Abstract][Full Text] [Related]
52. Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro.
Ibáñez-Costa A; Rivero-Cortés E; Vázquez-Borrego MC; Gahete MD; Jiménez-Reina L; Venegas-Moreno E; de la Riva A; Arráez MÁ; González-Molero I; Schmid HA; Maraver-Selfa S; Gavilán-Villarejo I; García-Arnés JA; Japón MA; Soto-Moreno A; Gálvez MA; Luque RM; Castaño JP
J Endocrinol; 2016 Nov; 231(2):135-145. PubMed ID: 27587848
[TBL] [Abstract][Full Text] [Related]
53. The third intracellular loop of the rat gonadotropin-releasing hormone receptor couples the receptor to Gs- and G(q/11)-mediated signal transduction pathways: evidence from loop fragment transfection in GGH3 cells.
Ulloa-Aguirre A; Stanislaus D; Arora V; Väänänen J; Brothers S; Janovick JA; Conn PM
Endocrinology; 1998 May; 139(5):2472-8. PubMed ID: 9564860
[TBL] [Abstract][Full Text] [Related]
54. Biological activity of somatostatin receptors in GC rat tumour somatotrophs: evidence with sst1-sst5 receptor-selective nonpeptidyl agonists.
Cervia D; Zizzari P; Pavan B; Schuepbach E; Langenegger D; Hoyer D; Biondi C; Epelbaum J; Bagnoli P
Neuropharmacology; 2003 Apr; 44(5):672-85. PubMed ID: 12668053
[TBL] [Abstract][Full Text] [Related]
55. Somatostatin inhibition of growth hormone release in goldfish: possible targets of intracellular mechanisms of action.
Kwong P; Chang JP
Gen Comp Endocrinol; 1997 Dec; 108(3):446-56. PubMed ID: 9405121
[TBL] [Abstract][Full Text] [Related]
56. Truncated somatostatin receptors as new players in somatostatin-cortistatin pathophysiology.
Córdoba-Chacón J; Gahete MD; Durán-Prado M; Luque RM; Castaño JP
Ann N Y Acad Sci; 2011 Mar; 1220():6-15. PubMed ID: 21388399
[TBL] [Abstract][Full Text] [Related]
57. Comparison of functional profiles at human recombinant somatostatin sst2 receptor: simultaneous determination of intracellular Ca2+ and luciferase expression in CHO-K1 cells.
Nunn C; Cervia D; Langenegger D; Tenaillon L; Bouhelal R; Hoyer D
Br J Pharmacol; 2004 May; 142(1):150-60. PubMed ID: 15037513
[TBL] [Abstract][Full Text] [Related]
58. Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells.
van der Hoek J; Waaijers M; van Koetsveld PM; Sprij-Mooij D; Feelders RA; Schmid HA; Schoeffter P; Hoyer D; Cervia D; Taylor JE; Culler MD; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E278-87. PubMed ID: 15769796
[TBL] [Abstract][Full Text] [Related]
59. Identification of critical residues involved in ligand binding and G protein signaling in human somatostatin receptor subtype 2.
Parry JJ; Chen R; Andrews R; Lears KA; Rogers BE
Endocrinology; 2012 Jun; 153(6):2747-55. PubMed ID: 22495673
[TBL] [Abstract][Full Text] [Related]
60. Somatostatin receptor-mediated suppression of gabaergic synaptic transmission in cultured rat retinal amacrine cells.
Chen W; Ke JB; Wu HJ; Miao Y; Li F; Yang XL; Wang Z
Neuroscience; 2014 Jul; 273():118-27. PubMed ID: 24846611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
